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Abstract: The photoactivatable amino acid p-benzoyl-L-phenylalanine (pBpa) has been used for
the covalent capture of protein–protein interactions (PPIs) in vitro and in living cells. However, this
technique often suffers from poor photocrosslinking yields due to the low reactivity of the active
species. Here we demonstrate that the incorporation of halogenated pBpa analogs into proteins leads to
increased crosslinking yields for protein–protein interactions. The analogs can be incorporated into live
yeast and upon irradiation capture endogenous PPIs. Halogenated pBpas will extend the scope of PPIs
that can be captured and expand the toolbox for mapping PPIs in their native environment.
Keywords: protein–protein interactions; covalent chemical capture; photocrosslinking;
p-benzoyl-L-phenylalanine
Introduction
Transient protein–protein interactions (PPIs) are critical
for the precise flow of information in cellular processes,
and misregulation of these interactions has been
implicated in an array of human diseases.1–4 There is
great interest in methods to successfully detect and
characterize these interactions. This is particularly
true because the often short (ns–ps) lifetimes and
moderate strengths (micromolar to millimolar dissoci-
ation constants) of these PPIs make them difficult to
study in their native environment using traditional
biochemical techniques.5–9 With the advance of amber
nonsense suppression, photoactivatable unnatural
amino acids (UAAs) such as p-benzoyl-L-phenylalanine
(pBpa) have been incorporated into proteins and used to
capture transient, moderate affinity interactions for
mechanistic purposes.10–28 For example, our lab and
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others have utilized pBpa to interrogate the interac-
tions involved in a variety of different cellular pro-
cesses, such as those between transcriptional activators
and their coactivator binding partners required for
transcriptional initiation and those between chaper-
ones and their substrates required for proper protein
folding.29–34
pBpa is activated for crosslinking through expo-
sure to UV light (350–365 nm). Upon irradiation, the
benzophenone carbonyl undergoes an n to π* transi-
tion to form a diradical species, and the triplet state can
abstract hydrogen atoms from activated C H bonds
and recombine to form a covalent adduct [Fig. 1(a)].
If an activated C H bond is not available, the triplet
state will relax back to the ground state and can be
reactivated.35,36 As a result, pBpa undergoes minimal
side reactions with solvent, making it particularly
useful for in vivo applications and for interaction
surfaces where considerable water is present. How-
ever, the low molar absorptivity and quantum yield
(εmax < 300 M
−1 cm−1; Φ = 0.05–0.4) of pBpa often
limits crosslinking yield. For example, significant
starting pBpa-containing protein is often observed
in experiments (Fig. S1).
Early mechanistic studies of benzophenone sug-
gest that the incorporation of electron-withdrawing
groups (EWGs) onto one or more of the aromatic rings
decreases the energy barrier for the n to π* transition
and concomitantly increases the rate of hydrogen
atom abstraction.35–39 Accordingly, we hypothesized
that pBpa analogs substituted with EWGs would
increase crosslinking yields [Fig. 1(b)]. Here, we dem-
onstrate that halogenated pBpa analogs can be incor-
porated into live yeast cells using the bioorthogonal
Escherichia coli tyrosyl tRNA/tRNA synthetase
(tRNATYRCUA/TyrRS) system and can capture in vivo
transcriptional activator–coactivator PPIs. Addition-
ally, the crosslinking yields for EWG-modified pBpa
are substantively enhanced.
Results and Discussion
The design of pBpa analogs containing EWGs was
influenced by the crystal structure of the E. coli tyrosyl
tRNA synthetase (PDB 1X8X) that would be used for
incorporation.40 Examination of the structure suggested
that the active site would likely accommodate substitu-
ents at the para position of the distal ring, but that meta
substituents would be more likely to experience steric
clashes (Fig. S2).41 Seven monosubstituted pBpa ana-
logs containing halogen moieties (Cl, F, Br, and CF3) at
either the meta or para positions of the benzophenone
ring were prepared via an air-tolerant carbonylative
Suzuki-Miyaura coupling with monosubstituted boronic
acids and 4-iodo-L-phenylalanine [Fig. 1(c)].42,43
The substituted pBpa analogs could be accessed
with high purity and excellent yields over five steps
Figure 1. (a) Covalent chemical capture mechanism of pBpa. Upon irradiation with 365 nm UV light, pBpa reversibly forms a
diradical species. If an activated C H bond is available, hydrogen atom abstraction followed by radical recombination will yield
the crosslinked adduct. (b) A series of pBpa analogs with halogen substituents either meta or para to the carbonyl group were
prepared. (c) Synthesis of halogenated pBpa analogs. Full experimental details and compound characterization can be found in
the supporting information.
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(see Supporting Information). The incorporation of
each analog was assessed in live yeast using the
E. coli tRNATYRCUA-TyrRS system.
40 We evaluated
the incorporation of each analog into the prototypical
Gal4 transcriptional activation domain (TAD) at posi-
tion 849, which has been well characterized for UAA
incorporation.30 Western blotting indicated that all
five of the para-substituted analogs were incorporated
into LexA-Gal4 at position 849 at levels comparable to
pBpa (Fig. 2). As suggested by the crystal structure,
substitution at the meta position was not well toler-
ated and sharp declines in incorporation were
observed with substituents larger than fluorine [Fig. 2
(c,d)]. Due to the failure of the synthetase to efficiently
incorporate the 3-CF3 Bpa analog, a 3-Br Bpa analog
was not prepared for evaluation. These findings are in
agreement with previous work byMehl and others that
have demonstrated bioorthogonal tRNA synthetases
developed for specific UAAs can incorporate analogs of
the cognate UAA without any further mutagenesis to
the active site.42,44–48 Furthermore, this suggests the
flexibility of the pBpa specific synthetase could enable
the use of a variety of pBpa analogs, particularly those
with substitution at the para position.
With the successful incorporation of the ana-
logs, the modified pBpa analogs were assessed for
their function as crosslinkers in vivo by examining
the well-defined PPI between Gal4 and its masking
protein, Gal80. In yeast, Gal4 interacts with the
Gal80 repressor through its TAD under normal glu-
cose conditions.49–51 Our lab has previously demon-
strated that pBpa incorporated in either the Gal4
TAD or Gal80 can capture this endogenous interac-
tion in live yeast. Because of the high incorporation
yields, the 3-F and 4-F Bpa analogs were selected
for comparison with pBpa in this model system.
Live yeast expressing a LexA + Gal4 fusion con-
struct with the amber mutation at position 849 and
a Myc epitope-tagged Gal80 were grown in glucose
in the presence of either pBpa or one of the fluorine
analogs [Fig. 3(a)]. Live cells were irradiated with
UV light to capture all Gal4 binding partners and
were then lysed and immunoprecipitated for the
LexA DNA binding domain to isolate all LexA + Gal4
protein interactions. To fully characterize the cross-
linking abilities of the UAAs, a duplex Western blotting
strategy was used such that both the binding profile of
Gal4 (red) and its direct interaction with Gal80 (green)
could be observed on the same Western blot (Fig. 3). As
seen in Figure 3(b), both fluorine-containing pBpa
analogs captured Gal4’s endogenous binding part-
ners, including the Gal4-Gal80 interaction (yellow).
It was not, however, possible to quantitatively deter-
mine a change in crosslinking yield in this system.
Figure 2. In vivo incorporation of halogenated pBpa analogs. (a) Position 849 was mutated to the amber stop codon (TAG) for
UAA incorporation within the LexA + Gal4 chimeric transcriptional activator. A C-terminal Flag tag was appended for visualization.
(b–e) Incorporation of the halogenated pBpa analogs into LexA + Gal4 849TAG in the presence or absence of 1 mM UAA. Loading
control is an endogenous yeast protein that consistently comes out with Flag visualization. (f) Relative expression levels of the
halogenated pBpa analogs compared to pBpa. Expression levels of LexA + Gal4 849UAA mutants relative to LexA + Gal4 WT
were quantified by using ImageJ.
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This is likely due to the high affinity of the Gal4Gal80
complex, which in turn results in high crosslinking
yields with even unmodified pBpa.49
To quantitate changes in crosslinking yield, we
identified an interaction that was more modest in affin-
ity and that also could be easily examined in vitro, thus
removing additional variables in vivo such as changes
in degradation rate that could influence any observa-
tions. The moderate affinity interaction between the
VP16 TAD and the Med25 subunit of the Mediator
complex was used for this quantitation.52,53 It has pre-
viously been shown that a minimal peptide sequence
(441-DFDLDMLG-448) within the N-terminal TAD of
VP16 is sufficient for interaction with the Med25 acti-
vator interaction domain (AcID) and transcriptional
activation.54–56 We hypothesized that incorporating
pBpa at position F442 would not abrogate binding with
Med25 AcID and would enable us to observe changes in
crosslinking efficiency for the pBpa analogs.
To determine the binding affinities, biotinylated
UAA-containing VP16 peptides were incubated with
Med25 coated plates. Following incubation with
streptavidin-HRP and tetramethylbenzidine (TMB)
substrate, the plates were read at 450 nm and it was
found that the binding affinities of each pBpa analog
containing VP16 peptides were minimally weakened
(two–threefold decrease in affinity) compared to the
parent pBpa peptide (Fig. S3).52,57 These values are
in line with the binding affinity of pBpa incorporated
VP16 measured by fluorescence polarization (Fig. S4).
To evaluate the crosslinking yield, Med25 was incu-
bated with each UAA-containing VP16 peptide at
12.5% of its Kd value to normalize for occupancy.
Following 10 minutes of UV irradiation with 365 nm
light to covalently capture the interaction, the amount
of crosslinked VP16 peptide was quantified by
Western blot analysis. As seen in Figure 4, all pBpa
analogs gave increased crosslinking yields, and the larg-
est increases were observed with the 3-CF3 (49-fold
increase), 3-Cl (30-fold increase), and 4-CF3 (23-fold
increase) analogs. Similar trends in reactivity for the
pBpa analogs were also observedwith 1-minute irradia-
tion time (Fig. S5). To further validate these results,
crosslinking yields were also analyzed via ELISA.
The biotinylated VP16 peptides were incubated with
Figure 3. LexA + Gal4 849UAA in vivo crosslinking.
(a) Experimental scheme of in vivo covalent chemical capture
of Gal4 binding partners. (b) 3-F and 4-F Bpa capture Gal4’s
endogenous binding partners (red) and the Gal4-Gal80
interaction (yellow) when irradiated with UV light.
Figure 4. VP16 (441-448) F442UAA in vitro crosslinking. Each
halogenated pBpa analog had increased crosslinking yield for
the Med25-VP16 adduct compared to pBpa upon UV
irradiation. (a) Western blot visualization of 6XHis + Med25:
Biotin + VP16 F442UAA in vitro crosslinking. Crosslinked
adducts visualized with Streptavidin-HRP and Med25 loading
visualized with anti-HIS-HRP antibody. (b) Relative fold change
in halogenated pBpa crosslinking yields compared to pBpa
from 6XHis + Med25:Biotin + VP16 F442UAA Western blot.
The yields are an average of two replicates. Crosslinking yields
were quantified using ImageJ. The relative amount of
Med25-VP16 crosslinked adducts for each sample was
normalized based on the protein levels of Med25 in the anti-
HIS-HRP blot. The fold changes were expressed as follows
(Med25-VP16 F442UAA crosslinked product/Med25-VP16
F442Bpa crosslinked product).
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Med25 coated plates and irradiated with 365 nm light.
Following washing and incubation with streptavidin-
HRP, the covalently captured VP16 peptide was visual-
ized by addition of TMB substrate [Fig. S6(A)]. Similar
trends in reactivity were observed [Fig. S6(B), S6(C)],
although the total increase in crosslinking yield is
lower. This can be attributed to higher background to
the format of the assay. Taken together, our results
support the predicted effect of appending electron
withdrawing groups onto the benzophenone frame-
work to decrease the excitation energy gap for the
n to π* transition of the carbonyl oxygen’s electrons,
thereby increasing the reactivity of the benzophenone
core and ultimately increasing the crosslinking yield
of themolecule.
Conclusions
Although pBpa has been shown to have lower reactiv-
ity compared to the other common photocrosslinking
groups such as the aryl azides and diazarines, its abil-
ity to be reactivated and minimal reactivity with sol-
vent makes it a strong tool for the covalent capture of
transient PPIs in vivo.14 Therefore, there was a need to
increase the crosslinking yield of pBpa to improve the
capture of PPIs and accelerate their characterization.
Based on previous studies with benzophenones, we
hypothesized that pBpa analogs substituted with elec-
tron withdrawing groups would increase crosslinking
yields. We synthesized seven monosubstituted pBpa
analogs (Fig. 1) and showed that upon irradiation of
live yeast expressing UAA-containing LexA + Gal4 we
capture Gal4’s endogenous binding partners, including
its masking protein Gal80. Furthermore, we demon-
strated in vitro that the halogenated pBpa analogs
increased crosslinking yields for weak transient inter-
actions. Taken together, we recommend the use of the
4-CF3 analog in cases where increased crosslinking
yield is needed as it is incorporated at similar levels to
pBpa and produced a 23-fold increase in crosslinking
yield.
Through this study, we have expanded our tool-
box of chemical probes for capturing challenging
PPIs in their native environment. We anticipate
that these halogenated pBpa analogs will have addi-
tional downstream applications post-crosslinking
and isolation. For instance, bromine and chlorine
atoms have enabled quantitative proteomic analysis
without the need for expensive isotopic labeling sys-
tems, such as stable isotope labeling using amino
acids in cell culture systems.58,59 Upon mass spec-
trometry analysis, the protein targets can be quanti-
fied between samples using the specific chlorine or
bromine isotopes to accurately identify interaction
partners with minimal bias between experimental
replicates. The unique isotopic signatures of these hal-
ogens could enable the identification of PPIs such as
low abundance activator–coactivator interactions that
may be drowned out by high-abundance proteins and
have eluded research efforts for years.60 Utilizing the
halogenated pBpa analogs developed will more read-
ily facilitate the successful implementation of in vivo
covalent capture for studying PPIs involved in a vari-
ety of biological processes.
Materials and Methods
UAA incorporation and expression
LS41 yeast was transformed with pLexA + Gal4
849 TAG-1X Flag or pLexA+Gal4WT-1X Flag and
pSNRtRNA-pBpaRS plasmids. Individual colonies were
grown in 5 mL synthetic complete (SC) media con-
taining 2% raffinose, but lacking histidine, tryptophan,
and uracil for selection. The cultures were incubated at
30 C with 250-rpm agitation. Following incubation,
these cultures were used to inoculate 5 mL cultures of
SC media containing 2% raffinose and 2% galactose,
with or without 1 mM pBpa/1 mM pBpa EWG analog
(dissolved in 50 μL 1M NaOH), and 50 μL 1M HCl. The
cultures were incubated at 30 C with agitation to an
OD660 of 1.0. Three ODs were isolated, washed with
sterile water, and stored at −20 C. The samples were
lysed in 10 μL 4× NuPAGE LDS Sample loading buffer
(Invitrogen), 10 μL 1× lysis buffer (50 mM Tris-Acetate
pH 7.9, 100 mM potassium acetate, 20% glycerol, 0.2%
Tween20, 2 mM β-mercaptoethanol, and 2 mM magne-
sium acetate), and 10 μL 1M DTT by boiling at 95 C
for 10 minutes. The samples were run on a 3–8% Tris-
acetate SDS-PAGE gel and analyzed by Western blot
with the anti-Flag (M2) antibody (Sigma-Aldrich).
Expression levels were quantified using ImageJ and
relative levels of LexA-Gal4 protein for each experi-
ment were expressed as follows ([experimental/WT
LexA-Gal4] × 100).
In vivo crosslinking analysis
A colony of LexA + Gal4 849 TAG-5X Flag:Gal80-6X
Myc was grown in 5 mL SC media containing 2% glu-
cose, but lacking histidine, tryptophan, leucine and
uracil for selection. The cultures were incubated at
30 C with 250-rpm agitation. Following incubation,
these cultures were used to inoculate 100 mL cul-
tures of SC media containing 2% glucose, with 1 mM
pBpa or 1 mM EWG pBpa analog (dissolved in 1 mL
1M NaOH), and 100 mL 1M HCl. The cultures were
incubated at 30 C with agitation to an OD660 of 1.0.
For each culture, the cells were isolated by centrifu-
gation and washed with the SC media lacking histi-
dine, tryptophan, and uracil. The cell pellets were
resuspended in 2 mL SC media containing 2% glucose
and then transferred to small culture dishes and
subjected to UV light at 365 nm (Eurosolar 15 W
UV lamp) with cooling for 30 minutes. The cells were
isolated by centrifugation and stored at −20 C until
lysis. The control samples were washed with 1 mL
SC media containing 2% glucose, isolated by centrifu-
gation, and stored at −20 C until lysis.
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For lysis, cells were resuspended in 600 μL lysis
buffer (50 mM HEPES – KOH pH 7.5, 140 mM NaCl,
1 mM EDTA, 1% Triton X-100, 0.1% Na-Deoxycholate
and 2× Complete Mini, EDTA Free Protease Inhibitor
[Roche]) and lysed using glass beads by vortexing
at 4 C. Subsequently, the lysate was pelleted and
the supernatant incubated with anti-LexA antibody
(sc-1725, Santa Cruz Biotechnologies) for 2 hours at
4 C for immunoprecipitation. The proteins bound to
the antibody were isolated by incubation for 1 hour
with 40-μL prewashed Dynabeads® protein G mag-
netic beads (ThermoFisher) at 4 C. After immuno-
precipitation, the beads were washed six times with
1 mL Wash Buffer (10 mM Tris–HCl pH 8.0, 250 mM
LiCl, 0.5% NP-40, 0.1% Na-Deoxycholate, and 1 mM
EDTA) and stored at −20 C until elution.
The samples were eluted from the beads by
heating at 95 C for 10 minutes in 10 μL NuPAGE
4× LDS Sample Loading Buffer (Invitrogen), 10 μL
water, and 10 μL 1M DTT. The samples were run on
a 4%–15% Mini-PROTEAN® TGX™ precast sodium
dodecylsulfate polyacrylimide gel electrophoresis
(SDS-PAGE) gel (Bio-Rad). The gel was transferred
to immobilon PVDF membrane (Millapore) and blocked
for 1 hour at room temperature using SuperBlock™
(PBS) blocking buffer (ThermoFisher). The membrane
was incubated with both mouse anti-Flag (M2) (Sigma-
Aldrich, F1804) and rabbit anti-cMyc (Sigma-Aldrich,
C3956) primary antibodies overnight at 4 C. The mem-
brane was washed three times for 10 minutes each with
PBS-T (10 mM Na2HPO47H2O, 1.7 mM KH2PO4,
140 mM NaCl, 3 mM KCl, 0.05% Tween-20, pH 7.4),
followed by incubation with anti-mouse 680 nm
(LI-COR, 926–68072) and anti-rabbit 800 nm (LI-COR,
926–32211) secondary antibodies for 1 hour at room
temperature. The membrane was washed three times
for 10 minutes each with PBS-T, 5 minutes with PBS
(10 mM Na2HPO47H2O, 1.7 mM KH2PO4, 140 mM
NaCl, 3 mM KCl, pH 7.4), and visualized using an
Azure c600 Western blot imager (Azure Biosystems).
In vitro crosslinking analysis
Med25 AcID 6x-His was diluted in binding buffer
(25 mM HEPES, 40 mM KCl, 8 mM MgCl2, 100 mM
NaCl, 0.01% Tween-20, pH 7.4) to 22 μM, and biotin
labeled VP16 peptides were diluted to 25% of their
Kd values in binding buffer. Equivalent volumes of
Med25 AcID and peptide were incubated at room tem-
perature for 30 minutes in a clear, flat bottom, polysty-
rene, 96-well plate (Fisherbrand). The solutions were
irradiated with UV light at 365 nm (Eurosolar 15 W
UV lamp) with cooling for 10 minutes. Fifteen microli-
ters of each sample was mixed with 5-μL NuPAGE
4× LDS Sample Loading Buffer (Invitrogen) and boiled
for 5 minutes. The samples were run on a 4%–20%
Mini-PROTEAN TGX precast SDS-PAGE gel (Bio-Rad).
The gel was transferred to PVDF membrane (Bio-Rad)
and blocked for 1 hour at room temperature with
SuperBlock (PBS) blocking buffer (ThermoFisher).
The membrane was incubated with 1:100 diluted
anti-HIS HRP-conjugated antibody (Santa Cruz
sc-8036 HRP) for 1 hour at room temperature. The
membrane was washed three times for 10 minutes
each with PBS-T (10 mM Na2HPO47H2O, 1.7 mM
KH2PO4, 140 mM NaCl, 3 mM KCl, 0.05% Tween-
20, pH 7.4), and visualized with SuperSignal West
Femto ECL substrate (ThermoFisher) using an Azure
c600 Western blot imager (Azure Biosystems). The
membrane was washed three times with PBS-T then
stripped by incubating in Restore Western blot strip-
ping buffer (ThermoFisher) for 45 minutes at 37 C.
The membrane was washed three times with PBS-T
then incubated with 1:2000 diluted HRP-conjugated
streptavidin (Abcam 7403) for 1 hour at room tempera-
ture. The membrane was washed three times for
10 minutes each with PBS-T and visualized with Sup-
erSignal West Femto ECL substrate (ThermoFisher)
using an Azure c600 Western blot imager (Azure
Biosystems). Crosslinking yields were quantified
using ImageJ. The relative amount of Med25-VP16
crosslinked product for each sample was normalized
based on the protein levels of Med25 in the HIS-
HRP blot. The fold changes were expressed as follows
(Med25-VP16 F442UAA crosslinked product/Med25-
VP16 F442Bpa crosslinked product)
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